Autologous Transplantation

Published results showed osteochondral allograft transplantation, autologous chondrocyte implantation and matrix-induced autologous chondrocyte implantation all yielded similar outcomes for patients with patellofemoral cartilage defects.

The FDA approved motixafortide combined with filgrastim for mobilization of hematopoietic stem cells into peripheral blood during collection for subsequent autologous transplantation in individuals with multiple myeloma.

Pure essential oils can reduce incidence of chemotherapy-induced nausea and vomiting among individuals who undergo bone marrow transplant, according to study results.

Multiple myeloma is the most common indication for autologous stem cell transplantation worldwide.

FORT LAUDERDALE, Fla.— Autologous transplantation of the internal limiting membrane showed comparable rates of macular hole closure but better visual outcomes than retina expansion surgery at 24 months of follow-up.

The addition of motixafortide to standard treatment improved hematopoietic stem cell target mobilization for autologous bone marrow transplantation among patients with multiple myeloma, according to the agent’s manufacturer.

Autologous hematopoietic stem cell transplant conferred favorable 2-year outcomes among older adults with multiple myeloma, according to study results presented at TCT Meetings Digital Experience.

Tanuja Chitnis, MD, senior neurologist at Brigham and Women’s Hospital and professor of neurology at Harvard Medical School and coauthor of the new National MS Guidelines, spoke with Healio about autologous hematopoietic stem cell transplant as treatment for MS.

Consolidation with nivolumab and brentuximab vedotin after autologous hematopoietic cell transplantation showed promise in patients with high-risk Hodgkin lymphoma, according to a presentation at the ASH Annual Meeting and Exposition.

Detection of circulating tumor DNA using immunoglobulin-based next generation sequencing within an apheresis stem cell sample predicted relapse after autologous stem cell transplantation among patients with diffuse large B-cell lymphoma.